Equities
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)25.70
  • Today's Change-0.300 / -1.15%
  • Shares traded299.00k
  • 1 Year change-7.89%
  • Beta--
Data delayed at least 15 minutes, as of Nov 22 2024 02:13 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy7
Outperform7
Hold2
Sell0
Strong Sell0

Share price forecast in CNY

The 13 analysts offering 12 month price targets for WuXi XDC Cayman Inc have a median target of 31.61, with a high estimate of 44.00 and a low estimate of 18.00. The median estimate represents a 21.59% increase from the last price of 26.00.
High69.2%44.00
Med21.6%31.61
Low-30.8%18.00

Earnings history & estimates in CNY

WuXi XDC Cayman Inc reported annual 2023 earnings of 0.26 per share on Mar 25, 2024.
More ▼

Revenue history & estimates in CNY

WuXi XDC Cayman Inc had revenues for the full year 2023 of 2.12bn. Last year the company did not report any revenues.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.